Bronchiectasis News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

FDA Advisory Group Sets Jan. 11 Review Date for Linhaliq, Potential Non-CF Bronchiectasis Therapy - Lung Disease News



Lung Disease News
 
FDA Advisory Group Sets Jan. 11 Review Date for Linhaliq, Potential Non-CF Bronchiectasis Therapy 
Lung Disease News
A committee of the U.S. Food and Drug Administration (FDA) will meet next month to review an application for Linhaliq to be approved for the treatment of patients with non-cystic fibrosis bronchiectasis (NCFBE) who have chronic lung infections with ...
FDA Advisory Group Set to Review Linhaliq, Potential Non-CF Bronchiectasis Treatment, on Jan. 11 Bronchiectasis News Today

all 2 news articles » 


Bronchiectasis More Prevalent in US Than Previously Thought, Study Finds - Bronchiectasis News Today



Bronchiectasis More Prevalent in US Than Previously Thought, Study Finds 
Bronchiectasis News Today
Of those, 31,122 were found to have been diagnosed with bronchiectasis in 2013. Patients had a mean age of 68. The most common comorbidities of bronchiectasis were chronic obstructive pulmonary disease (52%), acute bronchitis (38%), post-inflammatory ...

 


FDA Panel Opposes Approving Cipro DPI to Treat Non-CF Bronchiectasis - Bronchiectasis News Today



Bronchiectasis News Today
 
FDA Panel Opposes Approving Cipro DPI to Treat Non-CF Bronchiectasis 
Bronchiectasis News Today
A U.S. Food and Drug Administration (FDA) advisory panel voted not to recommend ciprofloxacin dry powder for inhalation (Cipro DPI), being developed by Bayer, to be approved for the treatment of non-cystic fibrosis bronchiectasis. Reasons given for ...
FDA Advisory Committee Advises Against Ciprofloxacin DPI MD Magazine

all 2 news articles » 


Mumbai smog leaves asthma, COPD patients gasping for clean air ... - Hindustan Times



Hindustan Times
 
Mumbai smog leaves asthma, COPD patients gasping for clean air ... 
Hindustan Times
The number of asthma, COPD and bronchiectasis cases have risen since last week, said Dr Nilkanth Awad, head of respiratory medicine at the Lokmanya Tilak Municipal General Hospital, Sion.

and more » 


Pseudomonas aeruginosa Infection in NCFBE Patients Leads to Higher Healthcare Costs, Study Finds - Bronchiectasis News Today



Bronchiectasis News Today
 
Pseudomonas aeruginosa Infection in NCFBE Patients Leads to Higher Healthcare Costs, Study Finds 
Bronchiectasis News Today
Patients who had two or more claims for bronchiectasis and more than one claim for P. aeruginosa infection were included in the analysis. Patients with cystic fibrosis were excluded. Results showed that the mean total healthcare cost per patient was ...

 


Bronchiectasis Drug Market Development and Trends Forecasts Report 2017-2022 - MilTech



Bronchiectasis Drug Market Development and Trends Forecasts Report 2017-2022 
MilTech
Bronchiectasis Drug Market report provides key statistics on the market status of the Bronchiectasis Drug Manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the Bronchiectasis Drug Industry. The ...

and more » 


COPD facts from the COPD Foundation - CBS News



CBS News
 
COPD facts from the COPD Foundation 
CBS News
From the COPD Foundation: What is COPD? Chronic Obstructive Pulmonary Disease (COPD) is an umbrella term used to describe progressive lung diseases, including refractory (non-reversible) asthma, some forms of bronchiectasis, chronic bronchitis and ...

and more » 


FDA Panel Says No to Inhaled Cipro for Severe Lung Infections - MedPage Today



FDA Panel Says No to Inhaled Cipro for Severe Lung Infections 
MedPage Today
SILVER SPRING, Maryland -- Citing inconsistent data, concerns about drug resistance and ability to meet only one of four primary endpoints in two studies, a majority of the FDA Antimicrobial Drugs Advisory Committee voted not to recommend ciprofloxacin ...

 


The relationship of SSRI and SNRI usage with interstitial lung disease and bronchiectasis in an elderly population ... - Dove Medical Press



The relationship of SSRI and SNRI usage with interstitial lung disease and bronchiectasis in an elderly population ... 
Dove Medical Press
Background: The association between interstitial lung disease (ILD) and selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors (SSRI/SNRI) has been previously described in published case reports. However, its ...

 


Bronchiectasis Market Pipeline Review H1 Development by Therapy Area, Stage of Development and Indication - satPRnews (press release)



Bronchiectasis Market Pipeline Review H1 Development by Therapy Area, Stage of Development and Indication 
satPRnews (press release)
Bronchiectasis Market Pipeline Review, H1 analysis report speaks about key players with pipeline review and targeted therapeutics covering drugs profile, Symptoms and Treatment includes of Bronchiectasis industry. The report delivers comprehensive ...

and more »